Inmed pharmaceuticals supports epidermolysis bullosa awareness week

Vancouver, british columbia, oct. 26, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development and manufacturing of rare cannabinoids, announces it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. epidermolysis bullosa global awareness week is october 25-31, 2022.
INM Ratings Summary
INM Quant Ranking